AstraZeneca COVID-19 Vaccine Linked To Another Rare Fatal Blood Clotting Disorder VITT
- 10 hours ago
A team of researchers has claimed that British-Swedish pharma giant AstraZeneca's COVID-19 vaccine has been found to raise the risk of VITT or vaccine-induced immune thrombocytopenia and thrombosis, a rare but fatal blood clotting disorder. This came after the company admitted that the vaccine, made in collaboration with Oxford University, can, in very rare cases, cause Thrombotic Thrombocytopenic Syndrome (TTS).
Mumbai Weather Forecast: IMD Predicts Heat Wave Conditions In The City And Suburbs On May 15
LatestLY
Who Is Contesting Under 'Clock' & 'Trumpet' Symbols In Maharashtra Lok Sabha Elections 2024?
LatestLY